| Literature DB >> 36032295 |
Natalia Kholod1, Andrey Koltsov1, Galina Koltsova1.
Abstract
African swine fever is a deadly disease of pigs caused by the large DNA virus (ASFV). Despite intensive research, little is known about the molecular mechanisms of ASFV pathogenesis. Transcriptome analysis of host and viral genes in infected macrophages revealed changes in expression of genes involved in various biological processes, including immune response, inflammatory response and apoptosis. To understand the mechanisms of virus pathogenesis, we used transcriptome analysis to identify the differences in gene expression between peripheral blood monocytes (PBMCs) isolated from pigs immunized with attenuated Congo ASFV strain (KK262), and then infected in vitro with virulent homologous Congo strain (K49) or heterologous Mozambique strain (M78). We found that overexpression of IFN-γ was detected only in cells infected with M78, although the expression of interferon-stimulated genes was increased in both types of cells. In addition, up-regulation of pro-inflammatory cytokines and chemokines was found in PBMCs infected with the heterologous strain M78, in contrast to the cells infected with K49. These data may indicate the beginning of an early immune response in cells infected with a heterologous, but not homologous strain. Transcriptome analysis revealed down-regulation of genes involved in endocytosis and phagocytosis in cells infected with the K49 strain, but not in PBMCs infected with M78. On the contrary, we detected activation of endoplasmic reticulum stress response genes in cells infected with a homologous strain, but not in cells infected with a heterologous strain. This study is the first attempt to determine the differences in the response to ASF infection between homologous and heterologous strains at the cellular level. Our results showed that not only genes of the immune response, but also genes involved in endocytosis and cellular stress response may be important for the formation of cross-protective immunity. This data may be useful for vaccine development or testing of candidate vaccines.Entities:
Keywords: African swine fever virus; heterologous ASFV strain; homologous ASFV strain; seroimmunotype; transcriptome
Year: 2022 PMID: 36032295 PMCID: PMC9411669 DOI: 10.3389/fvets.2022.936978
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
The number of differently expressed genes (DEG) in PBMCs infected with ASFV strains K49 or M78 (FDR ≤ 0.05).
|
|
|
|
|
|---|---|---|---|
| Total | 2,255 | 774 | 1,918 |
| Significantly up-regulated | 1,235 | 544 | 920 |
| Significantly down-regulated | 1,020 | 230 | 998 |
Neg, non-infected macrophages.
Biological pathways with up-regulated genes in PBMCs infected with both K49 and M78 strains (FDR ≤ 0.05).
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
| Response to virus | GO:0051607 | Defense response to virus | 42 | 3.3 × 10−10 | 36 | 4.2 × 10−17 |
| GO:0045071 | Negative regulation of viral genome replication | 14 | 3.1 × 10−4 | 12 | 3.6 × 10−6 | |
| R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 8 | 4.0 × 10−2 | 6 | 2.6 × 10−2 | |
| Interferon alpha/beta signaling | GO:0060337, R-HSA-909733 | Type I interferon signaling pathway | 23 | 4.7 × 10−7 | 23 | 3.4 × 10−13 |
| R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 9 | 2.4 × 10−3 | 8 | 1.1 × 10−4 | |
| GO:0032480, R-HSA-936440 | Negative regulation of type I interferon production | 11 | 2.4 × 10−3 | 9 | 2.1 × 10−4 | |
| R-HSA-933542 | TRAF6 mediated NF-kB activation | 9 | 1.7 × 10−2 | 7 | 7.1 × 10−3 | |
| Cytokine Signaling | GO:0060397, R-HSA-982772 | Growth hormone receptor signaling | 9 | 1.7 × 10−2 | 10 | 1.5 × 10−5 |
| GO:0007259 | JAK-STAT cascade | 10 | 2.0 × 10−2 | 10 | 4.0 × 10−5 | |
| Protein ubiquitination | GO:0000209 | Pprotein polyubiquitination | 25 | 8.8 × 10−2 | 15 | 4.0 × 10−2 |
Biological pathways with differently expressed genes in PBMCs infected with strain K49 compared to infected with strain M78 (FDR ≤ 0.05).
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
| Response to cellular stress | GO:0036499, R-HSA-380994 | PERK-mediated unfolded protein response | 7 | 4.0 × 10−3 |
| GO:1990440 | Positive regulation of transcription in response to ER stress | 6 | 3.9 × 10−2 | |
| GO:0030968 | Endoplasmic reticulum unfolded protein response | 17 | 8.1 × 10−7 | |
| GO:0042149 | Cellular response to glucose starvation | 8 | 8.2 × 10−2 | |
| Chromatin organization | GO:0000123 | Histone acetyltransferase complex | 9 | 1.1 × 10−3 |
| Protein phsophorylation | GO:0006468 | Protein phosphorylation | 46 | 1.7 × 10−2 |
| Translation | GO:0006418, R-HSA-379716 | tRNA aminoacylation for protein translation | 9 | 2.0 × 10−2 |
| Ubiquitination | GO:0004842 | Ubiquitin-protein transferase activity | 32 | 8.9 × 10−2 |
| GO:0016874 | Protein ligase activity | 29 | 4.8 × 10−2 | |
| mRNA decay | GO:1900153 | Deadenylation-dependent mRNA decay | 6 | 7.4 × 10−3 |
|
| ||||
| Endocytosis | GO:0035615 | Clathrin adaptor activity | 6 | 2.1 × 10−2 |
| GO:0030122 | AP-2 adaptor complex | 5 | 6.5 × 10−2 | |
Differential expression of interferon-stimulated genes in PBMCs infected with ASFV strains K49 or M78 (FDR ≤ 0.05).
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
| ||
| IFNG | 84 | 1.5 | 5.9 × 10−1 | 16.3 | 6.3 × 10−24 |
| BST2 | 429 | 6.0 | 3.6 × 10−42 | 4.7 | 1.8 × 10−32 |
| DDX58 | 718 | 8.6 | 5.5 × 10−104 | 5.6 | 6.9 × 10−61 |
| DDX60 | 153 | 3.9 | 7.3 × 10−9 | 5.7 | 1.8 × 10−19 |
| DHX58 | 304 | 8.6 | 5.5 × 10−104 | 5.6 | 6.9 × 10−61 |
| GBP2 | 354 | 4.3 | 1.3 × 10−35 | 3,5 | 4.9 × 10−26 |
| IFI44L | 817 | 3.0 | 2.5 × 10−38 | 2,7 | 2.7 × 10−34 |
| IFI6 | 579 | 5.0 | 7.7 × 10−60 | 2,3 | 2.2 × 10−14 |
| IFIH1 | 762 | 3.6 | 1.1 × 10−53 | 2,6 | 9.9 × 10−27 |
| IFIT1 | 1,069 | 6.5 | 8.3 × 10−80 | 4,3 | 3.8 × 10−61 |
| IFIT2 | 285 | 8.1 | 1.5 × 10−31 | 5,6 | 2.1 × 10−7 |
| IFIT5 | 161 | 8.2 | 8.7 × 10−26 | 3,5 | 1.5 × 10−6 |
| IFITM3 | 561 | 4.0 | 4.4 × 10−44 | 3,5 | 3.9 × 10−45 |
| IRF1 | 3,313 | 6.9 | 1.1 × 10−212 | 5,4 | 4.2 × 10−226 |
| ISG15 | 1,710 | 4.9 | 1.3 × 10−86 | 3,1 | 2.4 × 10−70 |
| ISG20 | 113 | 12.1 | 4.5 × 10−26 | 12,6 | 1.6 × 10−29 |
| MX1 | 2,659 | 5.9 | 6.9 × 10−144 | 4,4 | 3.4 × 10−37 |
| MX2 | 2,605 | 9.3 | 5.6 × 10−240 | 6,1 | 4.4 × 10−164 |
| OAS2 | 2,143 | 8.6 | 3.2 × 10−40 | 3,6 | 2.2 × 10−13 |
| RSAD2 | 580 | 8.3 | 2.7 × 10−76 | 5,1 | 3.4 × 10−50 |
| SOCS1 | 169 | 4.9 | 6.4 × 10−22 | 9,3 | 2.1 × 10−64 |
| SOCS3 | 2,525 | 2.4 | 5.9 × 10−53 | 4,8 | 1.6 × 10−243 |
| UBE2L6 | 1,051 | 4.2 | 5.1 × 10−76 | 3,3 | 4.4 × 10−59 |
Differential expression of cytokine genes in PBMCs infected with ASFV strains K49 or M78 (FDR ≤ 0.05).
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| IL10 | 670 | 4.3 | 9.6 × 10−48 | 5.8 | 6.3 × 10−77 | 1.3 | 6.6 × 10−2 |
| IL33 | 544 | 121.5 | 2.1 × 10−71 | 13.4 | 1.4 × 10−143 | 0.1 | 3.7 × 10−9 |
| IL6 | 86 | 16.2 | 8.2 × 10−19 | 44.6 | 2.9 × 10−22 | 2.7 | 2.8 × 10−1 |
| TNF | 366 | 4.9 | 5.1 × 10−35 | 7.0 | 1.9 × 10−57 | 1.4 | 1.1 × 10−1 |
Differential expression of chemokine genes in PBMCs infected with ASFV strains K49 or M78 (FDR ≤ 0.05).
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| CCL11 | 659 | 10.4 | 1.4 × 10−104 | 7.5 | 8.1 × 10−111 | 0.7 | 9.8 × 10−2 |
| CCL2 | 1,826 | 19.1 | 6.8 × 10−286 | 2.5 | 5.6 × 10−59 | 0.1 | 5.2 × 10−101 |
| CCL3L1 | 4,916 | 31.9 | 2.6 × 10−138 | 8.6 | 5.1 × 10−73 | 0.3 | 4.1 × 10−39 |
| CXCL10 | 1,169 | 2.5 | 3.9 × 10−4 | 69.6 | 2.1 × 10−50 | 27.3 | 5.6 × 10−36 |
| CXCL2 | 28,325 | 3.1 | 9.6 × 10−15 | 4.3 | 1.0 × 10−52 | 1.4 | 7.8 × 10−3 |
| CXCL8 | 38,980 | 2.2 | 2.7 × 10−12 | 7.1 | 1.2 × 10−106 | 3.3 | 2.1 × 10−106 |
| CXCL9 | 114 | 114.0 | 4.1 × 10−4 | 114.0 | 1.6 × 10−8 | ND | ND |
| AMCF-II | 17,678 | 13.34 | 1.0 × 10−23 | 3.55 | 1.7 × 10−232 | 0.27 | 5.7 × 10−7 |
ND, not determined.
Differential expression of genes involved in endocytosis and phagocytosis in PBMCs infected with ASFV strains K49 or M78 (FDR ≤ 0.05).
|
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| Endocytosis | AP2A2 | 409 | 1.6 | 1.7 × 10−5 | 0.7 | 4.5 × 10−4 | 0.5 | 5.2 × 10−17 |
| DAB2 | 66 | 10.9 | 2.5 × 10−13 | 2.3 | 7.3 × 10−5 | 0.2 | 2.1 × 10−4 | |
| HIP1 | 60 | 4.3 | 4.5 × 10−7 | 2.0 | 6.4 × 10−3 | 0.5 | 3.8 × 10−2 | |
| PICALM | 1,399 | 1.9 | 7.4 × 10−20 | 1.5 | 4.1 × 10−12 | 0.8 | 2.3 × 10−3 | |
| Phagocytosis | ACTB | 13,333 | 1.9 | 3.3 × 10−47 | 1.1 | 6.6 × 10−2 | 0.6 | 1.8 × 10−37 |
| ACTG1 | 6,318 | 2.3 | 6.6 × 10−62 | 1.3 | 2.2 × 10−9 | 0.6 | 1.1 × 10−30 | |
| ARPC5 | 1,779 | 2.2 | 3.4 × 10−32 | 1.1 | 7.0 × 10−2 | 0.5 | 1.2 × 10−22 | |
| FGR | 173 | 2.6 | 2.6 × 10−8 | 1.3 | 7.6 × 10−2 | 0.5 | 5.2 × 10−4 | |
| HCK | 347 | 2.3 | 8.5 × 10−12 | 1.3 | 1.7 × 10−2 | 0.6 | 1.6 × 10−5 | |
| LYN | 1,703 | 2.5 | 1.8 × 10−43 | 1.9 | 3.1 × 10−33 | 0.8 | 4.3 × 10−4 | |
| PIK3CB | 151 | 2.8 | 3.9 × 10−9 | 2.6 | 2.7 × 10−10 | 1.0 | 8.9 × 10−1 | |
| VAV1 | 1,496 | 2.3 | 1.1 × 10−34 | 1.8 | 1.7 × 10−23 | 0.8 | 1.8 × 10−3 | |
Differential expression of genes involved in cellular stress response in PBMCs infected with ASFV strains K49 or M78 (FDR ≤ 0.05).
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| ASNS | 589 | 0.2 | 2.4 × 10−66 | 1.3 | 3.2 × 10−1 | 6.5 | 1.9 × 10−77 |
| ATF4 | 6,933 | 0.4 | 4.5 × 10−63 | 1.1 | 1.9 × 10−2 | 2.7 | 2.8 × 10−86 |
| ATF6 | 732 | 0.6 | 2.5 × 10−8 | 0.9 | 7.9 × 10−1 | 1.5 | 5.5 × 10−7 |
| EIF2AK3 | 678 | 0.4 | 1.1 × 10−24 | 0.9 | 8.7 × 10−1 | 2.4 | 1.1 × 10−23 |
| XBP1 | 1,092 | 0.6 | 2.9 × 10−10 | 1.5 | 1.1 × 10−6 | 2.4 | 3.9 × 10−30 |
| SGK1 | 2,234 | 0.3 | 4.9 × 10−80 | 0.64 | 2.3 × 10−13 | 2.0 | 5.0 × 10−36 |